Collegium shareholders re-elect all eight directors and approve say-on-pay at 2024 annual meeting

COLLEGIUM PHARMACEUTICAL, INC

All eight director nominees re-elected; each received >98% of votes cast (For range: 25.4M-28.4M).
Advisory vote on executive compensation passed with 28,311,783 For (98.8% of votes cast).
Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 30,106,217 For.
Annual meeting held May 16, 2024; 31,059,529 shares present (94.9% of outstanding shares).
Broker non-votes were 2,360,841 on director and say-on-pay; 837,061 on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.